Vanguard Fiduciary Trust
PMVP icon

Vanguard Fiduciary Trust’s PMV Pharmaceuticals PMVP Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
254,775
-43,351
-15% -$55.6K ﹤0.01% 3407
2026
Q1 		$370K Buy
+298,126
New +$379K ﹤0.01% 3310

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Vanguard Fiduciary Trust's PMVP Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its PMV Pharmaceuticals (PMVP) stake by 15% in Q2 2026, selling an estimated $55.6K and leaving 254,775 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #3407.

Vanguard Fiduciary Trust first reported a position in PMVP in Q1 2026 and has held it in 2 quarters since. The position peaked at $370K in Q1 2026. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Vanguard Fiduciary Trust held 254,775 shares of PMV Pharmaceuticals worth $341K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 43,351 PMV Pharmaceuticals shares in Q2 2026, an estimated $55.6K.
  • PMV Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3407 holding.
  • Vanguard Fiduciary Trust first reported a position in PMV Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's PMV Pharmaceuticals position peaked at $370K in Q1 2026.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.